Skip to main content

News and Events

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

63 Results

Filters

Selected Filters

63 Results

R3 Seminar Recap: Impact of Long COVID on neurocognitive function

At the RECOVER Research Review (R3) Seminar held on April 14, RECOVER researchers presented findings on how Long COVID affects the brain, including difficulties with thinking clearly, memory, and concentration. They also outlined future research opportunities to better understand neurocognitive symptoms and how other body systems impact brain health. 

R3 Seminar Recap
Clinical Trial Observational Pathobiology Adult

RECOVER continues to focus on understanding symptoms that affect the brain

RECOVER researchers are continuing plans to explore cognitive symptoms like brain fog in the initiative’s adult observational study, one of the most common but least understood symptoms of Long COVID.

Feature
Clinical Trial Observational Adult

Honoring the many lived experiences with Long COVID

RECOVER recognizes International Long COVID Awareness Day on March 15—a day established by the Long COVID community to increase visibility of the condition, share resources, and educate the public.

Feature
Clinical Trial Observational EHR Pathobiology Adult Pediatric Pregnant Women

RECOVER Research Update: March 2026

Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.

Feature
Clinical Trial Observational EHR Pathobiology Review Adult Pediatric Pregnant Women

R3 Seminar Recap: Long COVID trajectories in adults

During the February 10, 2026, RECOVER Research Review (R3) Seminar, RECOVER researchers Sarah Donohue, PhD, MPH, and Tanayott (Tony) Thaweethai, PhD, presented research on Long COVID trajectories in adults. Published in November 2025, this research—which includes participants from the initiative’s adult observational cohort study—explores different clinical presentations of Long COVID and how the condition progresses over time. RECOVER Patient Representative and co-author Mady Hornig, MD, MA, and Timothy Henrich, MD, MMSc, a Long COVID researcher, also shared their perspectives and experiences. 

R3 Seminar Recap
Observational Adult

5 years in, RECOVER continues to advance its patient-centered mission

RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.

News Release
Clinical Trial Observational Pathobiology Adult Pediatric Pregnant Women

Pregnancy and pediatric studies work together to learn how COVID affects mothers and their babies

Babies whose mothers had COVID while pregnant will help RECOVER researchers understand how the mother’s COVID case could impact childhood development.

Feature
Observational Pediatric Pregnant Women

R3 Seminar Recap: Using RECOVER biosamples to advance your research

On January 13, 2026, RECOVER hosted the second webinar in its 2-part series to help prospective researchers use biosamples from the initiative’s observational studies. RECOVER has made over 1.4 million biosamples available for study across the human lifespan, including 24,000 samples from its tissue pathology (autopsy) study. This webinar is part of the RECOVER Research Review (R3) Seminar Series, which brings the scientific community together to accelerate diagnosing, preventing, and treating Long COVID.

R3 Seminar Recap
Observational Tissue Pathology Adult Pediatric Pregnant Women